SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-041422
Filing Date
2023-11-15
Accepted
2023-11-15 11:30:18
Documents
12
Period of Report
2023-11-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 47468
  Complete submission text file 0001493152-23-041422.txt   221799

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pcsa-20231114.xsd EX-101.SCH 3060
3 XBRL LABEL FILE pcsa-20231114_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE pcsa-20231114_pre.xml EX-101.PRE 22389
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3334
Mailing Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076
Business Address 7380 COCA COLA DRIVE SUITE 106 HANOVER MD 21076 443-776-3133
Processa Pharmaceuticals, Inc. (Filer) CIK: 0001533743 (see all company filings)

IRS No.: 451539785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39531 | Film No.: 231409595
SIC: 2834 Pharmaceutical Preparations